2015-2025 Global Drugs for Non-small Cell Lung Cancer Market Research by Type, End-Use and Region (COVID-19 Version)
SUMMARY
The global Drugs for Non-small Cell Lung Cancer market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Key Companies
The global Drugs for Non-small Cell Lung Cancer market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
- Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
- Chapter 2: Global Production & Consumption Market by Type and End-Use
- Chapter 3: Europe Production & Consumption Market by Type and End-Use
- Chapter 4: America Production & Consumption Market by Type and End-Use
- Chapter 5: Asia Production & Consumption Market by Type and End-Use
- Chapter 6: Oceania Production & Consumption Market by Type and End-Use
- Chapter 7: Africa Production & Consumption Market by Type and End-Use
- Chapter 8: Global Market Forecast by Type, End-Use and Region
- Chapter 9: Company information, Sales, Cost, Margin, news etc.
- Chapter 10: Market Competition by Companies and Market Concentration Ratio
- Chapter 11: Market Impact by Coronavirus.
- Chapter 12: Industry Summary
Key Companies
- Bristol-Myers Squibb
- GlaxoSmithKline
- Menarini
- Sanofi
- Ziopharm Oncology
- Alchemia
- Amgen
- Apotex
- BioMarin Pharmaceutical
- CellAct Pharma
- Cerulean Pharma
- Cipla
- Cornerstone Pharmaceuticals
- Curis
- CytRx
- Eli Lilly
- Exelixis
- Fresenius Kabi
- Genentech
- Hikma Pharmaceuticals
- Hospira
- Intas Pharmaceuticals
- Karyopharm Therapeutics
- Kyowa Hakko Kirin
- Ligand Pharmaceuticals
- Radiofrequency Ablation (RFA)
- Radiation Therapy
- Chemotherapy
- Targeted Therapies
- Immunotherapy
- Hospital
- Clinic
- Others
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Drugs for Non-small Cell Lung Cancer Production Forecast
Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Drugs for Non-small Cell Lung Cancer Forecast by Type
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2025 (Volume)
8.3 Global Drugs for Non-small Cell Lung Cancer Forecast by End-Use (2020E-2025F)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Drugs for Non-small Cell Lung Cancer Forecast by Region (2020E-2025F)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by Region in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
9.1.2 Bristol-Myers Squibb Products & Services
9.1.3 Bristol-Myers Squibb Company Dynamics & News
9.1.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.2.2 GlaxoSmithKline Products & Services
9.2.3 GlaxoSmithKline Company Dynamics & News
9.2.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Menarini
9.3.1 Menarini Profile
Table Menarini Overview List
9.3.2 Menarini Products & Services
9.3.3 Menarini Company Dynamics & News
9.3.4 Menarini Business Operation Conditions
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Sanofi
9.4.1 Sanofi Profile
Table Sanofi Overview List
9.4.2 Sanofi Products & Services
9.4.3 Sanofi Company Dynamics & News
9.4.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Ziopharm Oncology
9.5.1 Ziopharm Oncology Profile
Table Ziopharm Oncology Overview List
9.5.2 Ziopharm Oncology Products & Services
9.5.3 Ziopharm Oncology Company Dynamics & News
9.5.4 Ziopharm Oncology Business Operation Conditions
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Alchemia
9.6.1 Alchemia Profile
Table Alchemia Overview List
9.6.2 Alchemia Products & Services
9.6.3 Alchemia Company Dynamics & News
9.6.4 Alchemia Business Operation Conditions
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Amgen
9.7.1 Amgen Profile
Table Amgen Overview List
9.7.2 Amgen Products & Services
9.7.3 Amgen Company Dynamics & News
9.7.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Apotex
9.8.1 Apotex Profile
Table Apotex Overview List
9.8.2 Apotex Products & Services
9.8.3 Apotex Company Dynamics & News
9.8.4 Apotex Business Operation Conditions
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 BioMarin Pharmaceutical
9.9.1 BioMarin Pharmaceutical Profile
Table BioMarin Pharmaceutical Overview List
9.9.2 BioMarin Pharmaceutical Products & Services
9.9.3 BioMarin Pharmaceutical Company Dynamics & News
9.9.4 BioMarin Pharmaceutical Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 CellAct Pharma
9.10.1 CellAct Pharma Profile
Table CellAct Pharma Overview List
9.10.2 CellAct Pharma Products & Services
9.10.3 CellAct Pharma Company Dynamics & News
9.10.4 CellAct Pharma Business Operation Conditions
Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Cerulean Pharma
9.11.1 Cerulean Pharma Profile
Table Cerulean Pharma Overview List
9.11.2 Cerulean Pharma Products & Services
9.11.3 Cerulean Pharma Company Dynamics & News
9.11.4 Cerulean Pharma Business Operation Conditions
Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Cipla
9.12.1 Cipla Profile
Table Cipla Overview List
9.12.2 Cipla Products & Services
9.12.3 Cipla Company Dynamics & News
9.12.4 Cipla Business Operation Conditions
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
9.13 Cornerstone Pharmaceuticals
9.13.1 Cornerstone Pharmaceuticals Profile
Table Cornerstone Pharmaceuticals Overview List
9.13.2 Cornerstone Pharmaceuticals Products & Services
9.13.3 Cornerstone Pharmaceuticals Company Dynamics & News
9.13.4 Cornerstone Pharmaceuticals Business Operation Conditions
Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Curis
9.14.1 Curis Profile
Table Curis Overview List
9.14.2 Curis Products & Services
9.14.3 Curis Company Dynamics & News
9.14.4 Curis Business Operation Conditions
Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
9.15 CytRx
9.15.1 CytRx Profile
Table CytRx Overview List
9.15.2 CytRx Products & Services
9.15.3 CytRx Company Dynamics & News
9.15.4 CytRx Business Operation Conditions
Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
9.16 Eli Lilly
9.16.1 Eli Lilly Profile
Table Eli Lilly Overview List
9.16.2 Eli Lilly Products & Services
9.16.3 Eli Lilly Company Dynamics & News
9.16.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
9.17 Exelixis
9.17.1 Exelixis Profile
Table Exelixis Overview List
9.17.2 Exelixis Products & Services
9.17.3 Exelixis Company Dynamics & News
9.17.4 Exelixis Business Operation Conditions
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
9.18 Fresenius Kabi
9.18.1 Fresenius Kabi Profile
Table Fresenius Kabi Overview List
9.18.2 Fresenius Kabi Products & Services
9.18.3 Fresenius Kabi Company Dynamics & News
9.18.4 Fresenius Kabi Business Operation Conditions
Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
9.19 Genentech
9.19.1 Genentech Profile
Table Genentech Overview List
9.19.2 Genentech Products & Services
9.19.3 Genentech Company Dynamics & News
9.19.4 Genentech Business Operation Conditions
Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
9.20 Hikma Pharmaceuticals
9.20.1 Hikma Pharmaceuticals Profile
Table Hikma Pharmaceuticals Overview List
9.20.2 Hikma Pharmaceuticals Products & Services
9.20.3 Hikma Pharmaceuticals Company Dynamics & News
9.20.4 Hikma Pharmaceuticals Business Operation Conditions
Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.21 Hospira
9.21.1 Hospira Profile
Table Hospira Overview List
9.21.2 Hospira Products & Services
9.21.3 Hospira Company Dynamics & News
9.21.4 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
9.22 Intas Pharmaceuticals
9.22.1 Intas Pharmaceuticals Profile
Table Intas Pharmaceuticals Overview List
9.22.2 Intas Pharmaceuticals Products & Services
9.22.4 Intas Pharmaceuticals Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.23 Karyopharm Therapeutics
9.23.1 Karyopharm Therapeutics Profile
Table Karyopharm Therapeutics Overview List
9.23.2 Karyopharm Therapeutics Products & Services
9.23.3 Karyopharm Therapeutics Company Dynamics & News
9.23.4 Karyopharm Therapeutics Business Operation Conditions
Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
9.24 Kyowa Hakko Kirin
9.24.1 Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Overview List
9.24.2 Kyowa Hakko Kirin Products & Services
9.24.3 Kyowa Hakko Kirin Company Dynamics & News
9.24.4 Kyowa Hakko Kirin Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
9.25 Ligand Pharmaceuticals
9.25.1 Ligand Pharmaceuticals Profile
Table Ligand Pharmaceuticals Overview List
9.25.2 Ligand Pharmaceuticals Products & Services
9.25.3 Ligand Pharmaceuticals Company Dynamics & News
9.25.4 Ligand Pharmaceuticals Business Operation Conditions
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure America Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Asia Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Africa Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON DRUGS FOR NON-SMALL CELL LUNG CANCER INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 DRUGS FOR NON-SMALL CELL LUNG CANCER INDUSTRY SUMMARY & CONCLUSION
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Drugs for Non-small Cell Lung Cancer Production Forecast
Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Drugs for Non-small Cell Lung Cancer Forecast by Type
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2025 (Volume)
8.3 Global Drugs for Non-small Cell Lung Cancer Forecast by End-Use (2020E-2025F)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Drugs for Non-small Cell Lung Cancer Forecast by Region (2020E-2025F)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by Region in 2025 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
9.1.2 Bristol-Myers Squibb Products & Services
9.1.3 Bristol-Myers Squibb Company Dynamics & News
9.1.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.2.2 GlaxoSmithKline Products & Services
9.2.3 GlaxoSmithKline Company Dynamics & News
9.2.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Menarini
9.3.1 Menarini Profile
Table Menarini Overview List
9.3.2 Menarini Products & Services
9.3.3 Menarini Company Dynamics & News
9.3.4 Menarini Business Operation Conditions
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Sanofi
9.4.1 Sanofi Profile
Table Sanofi Overview List
9.4.2 Sanofi Products & Services
9.4.3 Sanofi Company Dynamics & News
9.4.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Ziopharm Oncology
9.5.1 Ziopharm Oncology Profile
Table Ziopharm Oncology Overview List
9.5.2 Ziopharm Oncology Products & Services
9.5.3 Ziopharm Oncology Company Dynamics & News
9.5.4 Ziopharm Oncology Business Operation Conditions
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Alchemia
9.6.1 Alchemia Profile
Table Alchemia Overview List
9.6.2 Alchemia Products & Services
9.6.3 Alchemia Company Dynamics & News
9.6.4 Alchemia Business Operation Conditions
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Amgen
9.7.1 Amgen Profile
Table Amgen Overview List
9.7.2 Amgen Products & Services
9.7.3 Amgen Company Dynamics & News
9.7.4 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Apotex
9.8.1 Apotex Profile
Table Apotex Overview List
9.8.2 Apotex Products & Services
9.8.3 Apotex Company Dynamics & News
9.8.4 Apotex Business Operation Conditions
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 BioMarin Pharmaceutical
9.9.1 BioMarin Pharmaceutical Profile
Table BioMarin Pharmaceutical Overview List
9.9.2 BioMarin Pharmaceutical Products & Services
9.9.3 BioMarin Pharmaceutical Company Dynamics & News
9.9.4 BioMarin Pharmaceutical Business Operation Conditions
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 CellAct Pharma
9.10.1 CellAct Pharma Profile
Table CellAct Pharma Overview List
9.10.2 CellAct Pharma Products & Services
9.10.3 CellAct Pharma Company Dynamics & News
9.10.4 CellAct Pharma Business Operation Conditions
Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Cerulean Pharma
9.11.1 Cerulean Pharma Profile
Table Cerulean Pharma Overview List
9.11.2 Cerulean Pharma Products & Services
9.11.3 Cerulean Pharma Company Dynamics & News
9.11.4 Cerulean Pharma Business Operation Conditions
Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Cipla
9.12.1 Cipla Profile
Table Cipla Overview List
9.12.2 Cipla Products & Services
9.12.3 Cipla Company Dynamics & News
9.12.4 Cipla Business Operation Conditions
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
9.13 Cornerstone Pharmaceuticals
9.13.1 Cornerstone Pharmaceuticals Profile
Table Cornerstone Pharmaceuticals Overview List
9.13.2 Cornerstone Pharmaceuticals Products & Services
9.13.3 Cornerstone Pharmaceuticals Company Dynamics & News
9.13.4 Cornerstone Pharmaceuticals Business Operation Conditions
Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Curis
9.14.1 Curis Profile
Table Curis Overview List
9.14.2 Curis Products & Services
9.14.3 Curis Company Dynamics & News
9.14.4 Curis Business Operation Conditions
Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
9.15 CytRx
9.15.1 CytRx Profile
Table CytRx Overview List
9.15.2 CytRx Products & Services
9.15.3 CytRx Company Dynamics & News
9.15.4 CytRx Business Operation Conditions
Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
9.16 Eli Lilly
9.16.1 Eli Lilly Profile
Table Eli Lilly Overview List
9.16.2 Eli Lilly Products & Services
9.16.3 Eli Lilly Company Dynamics & News
9.16.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
9.17 Exelixis
9.17.1 Exelixis Profile
Table Exelixis Overview List
9.17.2 Exelixis Products & Services
9.17.3 Exelixis Company Dynamics & News
9.17.4 Exelixis Business Operation Conditions
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
9.18 Fresenius Kabi
9.18.1 Fresenius Kabi Profile
Table Fresenius Kabi Overview List
9.18.2 Fresenius Kabi Products & Services
9.18.3 Fresenius Kabi Company Dynamics & News
9.18.4 Fresenius Kabi Business Operation Conditions
Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
9.19 Genentech
9.19.1 Genentech Profile
Table Genentech Overview List
9.19.2 Genentech Products & Services
9.19.3 Genentech Company Dynamics & News
9.19.4 Genentech Business Operation Conditions
Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
9.20 Hikma Pharmaceuticals
9.20.1 Hikma Pharmaceuticals Profile
Table Hikma Pharmaceuticals Overview List
9.20.2 Hikma Pharmaceuticals Products & Services
9.20.3 Hikma Pharmaceuticals Company Dynamics & News
9.20.4 Hikma Pharmaceuticals Business Operation Conditions
Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.21 Hospira
9.21.1 Hospira Profile
Table Hospira Overview List
9.21.2 Hospira Products & Services
9.21.3 Hospira Company Dynamics & News
9.21.4 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
9.22 Intas Pharmaceuticals
9.22.1 Intas Pharmaceuticals Profile
Table Intas Pharmaceuticals Overview List
9.22.2 Intas Pharmaceuticals Products & Services
9.22.4 Intas Pharmaceuticals Business Operation Conditions
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.23 Karyopharm Therapeutics
9.23.1 Karyopharm Therapeutics Profile
Table Karyopharm Therapeutics Overview List
9.23.2 Karyopharm Therapeutics Products & Services
9.23.3 Karyopharm Therapeutics Company Dynamics & News
9.23.4 Karyopharm Therapeutics Business Operation Conditions
Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
9.24 Kyowa Hakko Kirin
9.24.1 Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Overview List
9.24.2 Kyowa Hakko Kirin Products & Services
9.24.3 Kyowa Hakko Kirin Company Dynamics & News
9.24.4 Kyowa Hakko Kirin Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
9.25 Ligand Pharmaceuticals
9.25.1 Ligand Pharmaceuticals Profile
Table Ligand Pharmaceuticals Overview List
9.25.2 Ligand Pharmaceuticals Products & Services
9.25.3 Ligand Pharmaceuticals Company Dynamics & News
9.25.4 Ligand Pharmaceuticals Business Operation Conditions
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure America Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Asia Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
Figure Africa Drugs for Non-small Cell Lung Cancer Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON DRUGS FOR NON-SMALL CELL LUNG CANCER INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 DRUGS FOR NON-SMALL CELL LUNG CANCER INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2020E-2025F (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2020E-2025F (Volume)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Menarini Overview List
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ziopharm Oncology Overview List
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alchemia Overview List
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Pharmaceutical Overview List
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CellAct Pharma Overview List
Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cerulean Pharma Overview List
Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
Table Cornerstone Pharmaceuticals Overview List
Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Curis Overview List
Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
Table CytRx Overview List
Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
Table Exelixis Overview List
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
Table Fresenius Kabi Overview List
Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
Table Genentech Overview List
Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
Table Hikma Pharmaceuticals Overview List
Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Hospira Overview List
Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
Table Intas Pharmaceuticals Overview List
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Karyopharm Therapeutics Overview List
Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
Table Ligand Pharmaceuticals Overview List
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share by Companies, 2015-2020E (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table America Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Drugs for Non-small Cell Lung Cancer Revenue by Type, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2015-2020 (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Revenue by Type, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Production Volume by Type, 2020E-2025F (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Drugs for Non-small Cell Lung Cancer Consumption Volume by Region, 2020E-2025F (Volume)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Menarini Overview List
Table Business Operation of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ziopharm Oncology Overview List
Table Business Operation of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alchemia Overview List
Table Business Operation of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apotex Overview List
Table Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Pharmaceutical Overview List
Table Business Operation of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CellAct Pharma Overview List
Table Business Operation of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cerulean Pharma Overview List
Table Business Operation of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Business Operation of Cipla (Sales Revenue, Cost, Gross Margin)
Table Cornerstone Pharmaceuticals Overview List
Table Business Operation of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Curis Overview List
Table Business Operation of Curis (Sales Revenue, Cost, Gross Margin)
Table CytRx Overview List
Table Business Operation of CytRx (Sales Revenue, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
Table Exelixis Overview List
Table Business Operation of Exelixis (Sales Revenue, Cost, Gross Margin)
Table Fresenius Kabi Overview List
Table Business Operation of Fresenius Kabi (Sales Revenue, Cost, Gross Margin)
Table Genentech Overview List
Table Business Operation of Genentech (Sales Revenue, Cost, Gross Margin)
Table Hikma Pharmaceuticals Overview List
Table Business Operation of Hikma Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Hospira Overview List
Table Business Operation of Hospira (Sales Revenue, Cost, Gross Margin)
Table Intas Pharmaceuticals Overview List
Table Business Operation of Intas Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Karyopharm Therapeutics Overview List
Table Business Operation of Karyopharm Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Cost, Gross Margin)
Table Ligand Pharmaceuticals Overview List
Table Business Operation of Ligand Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Drugs for Non-small Cell Lung Cancer Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume by Companies, 2015-2020E (Volume)
Table Global Drugs for Non-small Cell Lung Cancer Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2025 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2025 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by Region in 2025 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by Region in 2025 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDrugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2020 (Volume)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Drugs for Non-small Cell Lung Cancer Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Revenue Share by Type in 2025 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Production Volume Share by Type in 2025 (Volume)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Value Share by Region in 2025 (Million USD)
Figure Global Drugs for Non-small Cell Lung Cancer Consumption Volume Share by Region in 2025 (Volume)
